CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)1 - USD ($)	9 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)
Net loss	$ 28,238,682	$ 28,156,252
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,845,978	1,649,699
Share-based payments for services	603,147	955,900
Equity based compensation	9,102,774	10,090,410
Common stock contributed to 401(k) plan	(167,280)	(146,296)
Gain on short-term investments	615	6,578
Loss on patent impairment	30,793	0
Gain (loss) on derivative instruments	366,791	(991,562)
Modification of warrants	(634,713)	(24,387)
(Increase)/decrease in assets:
Receivables	(54,922)	0
Prepaid expenses	(147,192)	(232,752)
Supplies used for R&D and manufacturing	(166,453)	(759,193)
Deposits	1,910,917	(248,712)
Increase/(decrease) in liabilities:
Accounts payable	(410,536)	689,812
Accrued expenses	78,729	297,928
Due to employees	230,012	84,598
Other liabilities	49,390	22,459
Net cash used in operating activities	(13,327,230)	(13,984,932)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturity (purchases) of US treasury bills	6,152,000	(11,145,667)
Purchases of property and equipment	(621,826)	(8,628,648)
Expenditures for patent costs	(22,741)	0
Net cash provided by (used in) investing activities	5,507,433	(19,774,315)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	0	47,363,426
Share issuance costs	(50,515)	(207,673)
Proceeds from exercises of warrants and options	131,060	6,195,571
Proceeds from landlord funding of leasehold improvements	786,454	1,613,546
Payments on obligations under finance lease	(1,033,677)	(756,817)
Net cash (used in) provided by financing activities	(166,678)	54,208,053
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(7,986,475)	20,448,806
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	36,060,148	15,508,909
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 28,073,673	$ 35,957,715